S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Arbutus BiopharmaTrevenaNextCureMEI PharmaFortress Biotech
SymbolNASDAQ:ABUSNASDAQ:TRVNNASDAQ:NXTCNASDAQ:MEIPNASDAQ:FBIO
Price Information
Current Price$3.81$2.19$11.56$3.70$3.71
52 Week RangeBuyBuyHoldBuyBuy
MarketRank™
Overall Score1.41.41.61.71.3
Analysis Score3.43.53.13.43.5
Community Score2.83.32.62.82.6
Dividend Score0.00.00.00.00.0
Ownership Score0.00.01.71.70.0
Earnings & Valuation Score0.60.00.60.60.6
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$6.29$5.00$23.33$10.60$10.55
% Upside from Price Target64.98% upside128.31% upside101.85% upside186.49% upside184.37% upside
Trade Information
Market Cap$323.50 million$343.90 million$318.51 million$416.35 million$347.64 million
Beta3.152.59-0.41.652.43
Average Volume3,214,4913,770,311266,1651,183,336673,120
Sales & Book Value
Annual Revenue$6.01 million$30,000.00$6.35 million$28.91 million$36.63 million
Price / Sales53.8311,463.1950.1614.409.49
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($1.00) per share$0.32 per share$14.13 per share$0.74 per share$1.02 per share
Price / Book-3.816.840.825.003.64
Profitability
Net Income$-153,720,000.00$-24,870,000.00$-33,740,000.00$-46,010,000.00$-39,960,000.00
EPS($1.62)($0.27)($2.15)($0.26)($0.73)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-1,163.48%N/AN/A-142.81%-131.98%
Return on Equity (ROE)N/A-42.49%-10.00%-33.55%-44.08%
Return on Assets (ROA)-59.66%-34.83%-9.51%-16.70%-19.06%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.01%N/A0.29%
Current Ratio15.94%28.08%51.73%6.48%6.38%
Quick Ratio15.94%28.08%51.73%6.48%6.35%
Ownership Information
Institutional Ownership Percentage28.44%11.62%66.30%67.61%32.13%
Insider Ownership Percentage6.70%5.20%9.05%4.42%29.50%
Miscellaneous
Employees7824695193
Shares Outstanding84.91 million157.03 million27.55 million112.53 million93.70 million
Next Earnings Date3/4/2021 (Confirmed)3/11/2021 (Estimated)3/11/2021 (Estimated)5/6/2021 (Estimated)3/15/2021 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.